Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual and multi-targeted nanoparticles for site-specific brain drug delivery
Yan Luo, Hang Yang, Yifan Zhou, et al.
Journal of Controlled Release (2019) Vol. 317, pp. 195-215
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies
Farshad Moradi Kashkooli, M. Soltani, Mohammad Souri
Journal of Controlled Release (2020) Vol. 327, pp. 316-349
Closed Access | Times Cited: 390
Size, shape, charge and “stealthy” surface: Carrier properties affect the drug circulation time in vivo
Jinwei Di, Xiang Gao, Yimeng Du, et al.
Asian Journal of Pharmaceutical Sciences (2020) Vol. 16, Iss. 4, pp. 444-458
Open Access | Times Cited: 188
Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release
Shaobo Ruan, Yang Zhou, Xinguo Jiang, et al.
Advanced Science (2021) Vol. 8, Iss. 9
Open Access | Times Cited: 148
Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrier
Hafiz Ahmed, Shyam Sudhakar Gomte, Eluri Prathyusha, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 76, pp. 103729-103729
Closed Access | Times Cited: 106
Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands
Ricardo Moreira, Clévio Nóbrega, Luís Pereira de Almeida, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Jun Liao, Wenxiu He, Lisha Li, et al.
(2025), pp. 100016-100016
Open Access | Times Cited: 2
Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Farshad Moradi Kashkooli, M. Soltani, Mohammad Souri, et al.
Nano Today (2020) Vol. 36, pp. 101057-101057
Closed Access | Times Cited: 100
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials
Guowang Cheng, Yujing Liu, Rui Ma, et al.
Nano-Micro Letters (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 66
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics
Melgious Jin Yan Ang, Siew Yin Chan, Yi Yiing Goh, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113907-113907
Closed Access | Times Cited: 62
Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease
Kang Qian, Xiaoyan Bao, Yixian Li, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 11455-11472
Closed Access | Times Cited: 57
Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery
Shamama Javed, Bharti Mangla, Yosif Almoshari, et al.
Nanotechnology Reviews (2022) Vol. 11, Iss. 1, pp. 1744-1777
Open Access | Times Cited: 46
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
Nikhil Pandey, Pavlos Anastasiadis, Christine P. Carney, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114415-114415
Open Access | Times Cited: 40
Multi-Stimuli-Responsive and Cell Membrane Camouflaged Aggregation-Induced Emission Nanogels for Precise Chemo-photothermal Synergistic Therapy of Tumors
Liping Zhang, Zaiyu Wang, Rongyuan Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 25205-25221
Open Access | Times Cited: 33
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Francisco Branco, Joana Cunha, Maria Mendes, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16359-16394
Open Access | Times Cited: 12
Challenges and Material Innovations in Drug Delivery to Central Nervous System Tumors
Zhenyu Gong, Dairan Zhou, Dejun Wu, et al.
Biomaterials (2025) Vol. 319, pp. 123180-123180
Closed Access | Times Cited: 1
Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner
Monika Nehra, U.T. Uthappa, Virendra Kumar, et al.
Journal of Controlled Release (2021) Vol. 338, pp. 224-243
Closed Access | Times Cited: 53
Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects
Elham Aram, Masome Moeni, Roya Abedizadeh, et al.
Nanomaterials (2022) Vol. 12, Iss. 20, pp. 3567-3567
Open Access | Times Cited: 33
New Drug Delivery Systems Developed for Brain Targeting
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 32
pH-redox responsive cascade-targeted liposomes to intelligently deliver doxorubicin prodrugs and lonidamine for glioma
Yi Zhao, Yao Peng, Zhongzhen Yang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 235, pp. 114281-114281
Closed Access | Times Cited: 29
PEGylated Manganese–Zinc Ferrite Nanocrystals Combined with Intratumoral Implantation of Micromagnets Enabled Synergetic Prostate Cancer Therapy via Ferroptotic and Immunogenic Cell Death
Hui Wang, Yu Guan, Chun Li, et al.
Small (2023) Vol. 19, Iss. 22
Closed Access | Times Cited: 22
Emerging nanotechnology for Alzheimer's disease: From detection to treatment
Nan Song, Si Sun, Ke Chen, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 392-417
Closed Access | Times Cited: 21
Polylactic-Co-Glycolic Acid-Based Nanoparticles Modified with Peptides and Other Linkers Cross The Blood–Brain Barrier for Targeted Drug Delivery
Yue Na, Ning Zhang, Xinyu Zhong, et al.
Nanomedicine (2023) Vol. 18, Iss. 2, pp. 125-143
Closed Access | Times Cited: 18
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases
Sanaz Keshavarz Shahbaz, Khadije Koushki, Samaneh Keshavarz Hedayati, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2793-2824
Closed Access | Times Cited: 7
Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy
Zichen Zhong, Wen Deng, Jian Wu, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8708-8738
Closed Access | Times Cited: 6
Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy
Huai‐An Chen, Yunn‐Hwa Ma, Tzu-Yuan Hsu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2690-2690
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top